Treatment sequencing: use protease inhibitors first. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
Gulick
R M
RM
Weill Medical College, Cornell University, New York, USA.
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D002423:Cause of Death; D004279:DNA, Viral / Q000187:drug effects / Q000235:genetics; D004334:Drug Administration Schedule; D024882:Drug Resistance, Viral / Q000235:genetics; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D015497:HIV-1 / Q000235:genetics; D006801:Humans; D008297:Male; D009017:Morbidity; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018894:Reverse Transcriptase Inhibitors; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D019380:Anti-HIV Agents; D004279:DNA, Viral; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase